US/UK/Canada

Share

Contacts

  • Pär Teike

    CEO


    Cell Impact Källmossvägen 7A 691 52 Karlskoga Sweden
    +46 73-024 06 84
    https://www.cellimpact.com

    • Links

    Pick a time period -
    Tags ( Active)

    Cell Impact signs agreement valued at 3.2 million SEK

    A leading Japanese, global supplier has placed an order with F.C.C., encompassing design, tools, and prototypes, which Cell Impact AB (publ) will deliver.The order is a direct result of the elaborated collaboration between Cell Impact AB (publ) and Japanese company F.C.C. Co., Ltd., which commenced with the installation of a demonstration line at F.C.C.’s facility in late 2022. “The company that placed the order was one of the companies that evaluated Cell Impact Forming™, our unique and patented forming technology, at F.C.C. The order includes the design of tools and flow plates, as

    Communiqué from the Annual General Meeting 2024 of Cell Impact AB (publ)

    The annual general meeting of Cell Impact AB (publ) was held on 25 April 2024.Adoption of the profit and loss account and balance sheet as well as profit allocationThe annual general meeting approved the balance sheets and income statements included in the annual report for the financial year 2023 and resolved, in accordance with the proposal of the board of directors, that available profits of SEK 224,834,136 should be carried forward. Board of directors and auditorThe annual general meeting granted the directors of the board and the CEO discharge from liability for the financial

    Notice of the annual general meeting of Cell Impact (publ)

    The shareholders of Cell Impact AB (publ), reg. no. 556576-6655, are hereby invited to participate in the annual general meeting to be held on Thursday 25 April 2024, 14.00 hours (CET) at the premises of Sturegatan 15 Konferens & Event on Sturegatan 15 in Stockholm, Sweden. Registration starts at 13.30 hours (CET).Registration and notification Participation at the venue A shareholder who wishes to participate in the annual general meeting at the venue, in person or represented by proxy: · must be recorded as a shareholder in the share register maintained by Euroclear Sweden AB

    Cell Impact publishes annual report for 2023

    Cell Impact AB (publ) has now published the annual report for 2023 on its website: www.cellimpact.com.  On the website, both the Swedish and English version are available.As already mentioned, 2023 was a weak year, but Cell Impact managed to secure funding for the company’s ongoing development before year-end, concluded the cost-reduction program launched in July 2023 and initiated yet another. After the end of the year, the company received its first order for flow plates within the area of electrolysis. Turnover for 2023 amounted to SEK 47.3 million (76.8), a decrease of 38 percent.

    Cell Impact Meets Representatives of the Hydrogen Industry in the United States

    Cell Impact has been selected by Business Sweden to participate in a Swedish delegation trip to Texas and California focused on green hydrogen. The purpose is to explore partnerships between American and Swedish companies. Representing Cell Impact on this journey is Henrik Jackman.The delegation trip will take place from March 18th to 22nd and is part of the green hydrogen program developed by the Swedish Energy Agency and Business Sweden. The goal is to provide Swedish companies with insights into the significant U.S. investment in sustainable hydrogen and to introduce Swedish solutions

    Cell Impact has received an order worth SEK 18 million in the field of electrolysis

    Cell Impact has signed an agreement concerning flow plates, tools, and fixtures to a value of just over SEK 18 million. The contract marks a significant step for Cell Impact into the electrolyzer market.The agreement, spanning 30 months, introduces a new market segment for Cell Impact as well as a new, European customer. The customer boasts a promising unique technology for manufacturing PEM electrolyzers. The project is set to begin in March 2024, with deliveries initially expected to continue until mid-2026. “One of the advantages of this customer's technical solution is that it allows

    Cell Impact Q4 2023: Expected weak quarter but financing secured

    The fourth quarter turned out to be very weak as previously announced, but Cell Impact’s sales will gradually increase in the coming quarters, albeit from a low level. During the quarter, financing for the company's ongoing development was secured, the cost reduction program announced in July 2023 was concluded and an additional cost reduction program was initiated. Our full focus is now directed toward developing both customer projects and taking further steps in Phase II, our productivity and profitability program.The company’s sales will gradually increase in the coming quarters, not

    Malin Lundberg appointed CFO of Cell Impact AB

    Cell Impact AB (Nasdaq First North GM: CI B) announces that Malin Lundberg has been appointed Chief Financial Officer (CFO) effective February 12, 2024.Malin Lundberg has a Master of Science in Business and Economics and comes most recently from the role of Business Controller at Cell Impact, where she started in 2021. Previously she has worked primarily with accounting within PwC and Baker Tilly, among others. Malin Lundberg takes over from Stefan Axellie, who ensures a comprehensive handover. - I am pleased that Malin wants to continue to develop with us. Malin's knowledge in

    Pär Teike leaves the role as CEO of Cell Impact AB

    Pär Teike, CEO since 2017, has decided to leave his role and Cell Impact. Daniel Vallin, Cell Impact's COO since 2021, is proposed to take over as acting CEO from January 1, 2024, until a decision is made regarding a permanent CEO of Cell Impact. Daniel Vallin, 46 years old, is a Master of Science in Industrial Engineering with extensive industrial experience from among others, Scania CV AB."We are at the end of the year and one can reflect on what has been but also look ahead. Together with my rather international family, I have landed in a decision that it is time to turn page and spend

    First day of trading in warrants of series 2023/2024 TO2

    In December 2023, Cell Impact AB (publ) (Nasdaq First North Growth Market: CI) ("Cell Impact" or the "Company") carried out a rights issue of Units (the “Rights Issue”). The first day of trading in warrants of series 2023/2024 TO2 (the "Warrants") issued as part of the Rights Issue on Nasdaq First North Growth Market is tomorrow, 19 December 2023. The last day of trading in the Warrants is 25 September 2024. The Warrants will be traded under the short name (ticker) CI TO2.Through the Rights Issue, 128,905,776 Warrants have been issued. Each Warrant entitles the holder to subscribe for

    Stefan Axellie to leave role as CFO for Cell Impact AB

    Stefan Axellie, CFO of Cell Impact since 2020, has decided to leave his role and Cell Impact by spring 2024.“I have spent four years with Cell Impact which have been both intensive and exiting, but I now feel that it is a good time for me to pursue other challenges,” explains Stefan Axellie. “Stefan has been a key member of Cell Impact’s executive management since 2020. He has strongly contributed to the company’s development and is an appreciated leader and colleague,” comments Pär Teike CEO, Cell Impact. The process of identifying a successor will start within short. Stefan Axellie

    Cell Impact announces final outcome in the company’s partly guaranteed rights issue

    THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO BUY SECURITIES IN CELL IMPACT AB (PUBL). SEE ALSO THE SECTION “IMPORTANT INFORMATION” BELOW IN THIS DOCUMENT.Today, Cell Impact AB (publ) (Nasdaq First North Growth Market: CI) ("Cell Impact" or the "Company") announces the final outcome of the Company's rights

    Cell Impact publishes prospectus relating to the rights issue

    THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL. SEE ALSO THE SECTION "IMPORTANT INFORMATION" BELOW IN THIS DOCUMENT.On 8 November 2023, Cell Impact AB (publ) (Nasdaq First North Growth Market: CI) (“Cell Impact” or the “Company”) announced that the Board of Directors, by virtue of the authorization granted by the extraordinary general meeting held on 3

    The Board of Directors in Cell Impact has resolved on the previously announced rights issue of up to approximately SEK 152 million

    THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO BUY SECURITIES IN CELL IMPACT AB (PUBL). SEE ALSO THE SECTION “IMPORTANT INFORMATION” BELOW IN THIS DOCUMENT.The Board of Directors in Cell Impact AB (Nasdaq First North Growth Market: CI) (“Cell Impact” or the “Company”) has today, by virtue of the

    Bulletin from the Extraordinary General Meeting 2023 of Cell Impact AB (publ)

    The extraordinary general meeting of Cell Impact AB (publ) was held on 3 November 2023.Resolution regarding amendments to the articles of associationThe general meeting resolved in accordance with the board’s two proposals on amendments to 4-5 §§ of the articles of association, entailing: partly that the articles of association shall be amended so that the share capital shall be not less than SEK 23,151,250 and not more than SEK 92,605,000, and that the number of shares shall be not less than 200,000,000 and not more than 800,000,000, partly that the articles of association shall be

    Cell Impact Q3 2023: Low demand but continued high interest

    Cell Impact AB (Nasdaq First North GM: CI) reports the following summary for the third quarter 2023.The third quarter was a weak period in line with the expectations that Cell Impact communicated after the second quarter. Net sales during the third quarter of the year amounted to SEK 9.3 million (17.0) and the operating loss was SEK -23.7 million (-28.6). As communicated after the second quarter, there is lower demand for flow plates in particular. To adapt the company’s organization to these new conditions, Cell Impact implemented a cost reduction program during the third quarter that

    The Board of Directors in Cell Impact intends to resolve on a rights issue of up to approximately SEK 152 million and announces preliminary EBIT for Q3 2023

    THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO BUY SECURITIES IN CELL IMPACT AB (PUBL). SEE ALSO THE SECTION “IMPORTANT INFORMATION” BELOW IN THIS DOCUMENT.The Board of Directors in Cell Impact AB (Nasdaq First North Growth Market: CI) (“Cell Impact” or the “Company”) today announces its intention to resolve

    Notice of Extraordinary General Meeting in Cell Impact AB (publ)

    Cell Impact AB (publ), Reg. No. 556576-6655, with its registered office in Karlskoga, gives notice of the Extraordinary General Meeting to be held on 3 November 2023 at 10 a.m. CET in Advokatfirman Vinge’s premises on Smålandsgatan 20, 111 46 Stockholm, Sweden. Registration starts at 9.30 a.m. CET.Right to participate in the Extraordinary General Meeting and notice of participation Participation at the venueA shareholder who wishes to participate in the General Meeting at the venue in person or represented by a proxy must (i) be recorded as a shareholder in the share register

    Cell Impact publishes operational update, announces preliminary sales figures for the third quarter 2023 and will convene an EGM to create flexibility in upcoming capital raising

    The trend of delayed orders from fuel cell manufacturers, that Cell Impact communicated in the interim report for the second quarter of 2023, continues and the tendency is stronger than before.Net sales during the third quarter preliminarily amounted to approximately SEK 8 million (17), which is less than expected. The trend of delayed orders from the second quarter continues and the tendency is stronger than before. Sales during the third quarter of the year consisted mainly of flow plates, while delays were experienced in terms of expected tooling projects and equipment. The company

    Cell Impact receives SEK 22.0 million order from Plug Power

    Cell Impact has received an order worth SEK 22.0 million from world-leading fuel cell and electrolysis supplier Plug Power Inc. for production of flow plates and supply of related products for delivery during the first half of 2024.”Cell Impact is very excited to have received this order from Plug Power for continuous production of flow plates and other supplies over the coming year. This means that Cell Impact is continuing to support the growth of a world leader in the fuel cell and electrolysis industry and contributing toward reducing carbon emissions,” said Pär Teike, Cell Impact’s CEO.

    Cell Impact participates in the Stuttgart hy-fcell conference and exhibition

    Cell Impact participates in hy-fcell in Stuttgart, Germany, one of the world’s largest and most important hydrogen technology industry events. Cell Impact will present the company’s flow plate production offer based on the unique forming technology Cell Impact Forming[TM].Flow plate production is critically important for the growth of the hydrogen industry and at hy-fcell, Cell Impact will share its experiences and knowledge from more than 50 flow plate projects involving a wide range of applications and materials. Cell Impact’s production offer involving Cell Impact Forming, an

    Cell Impact participates in H2 MEET hydrogen technology event at KINTEX, South Korea

    Cell Impact participates in H2 MEET in Seoul, South Korea, one of the world’s largest and most important hydrogen technology industry events. Cell Impact will present Cell Impact Forming[TM], the company’s unique flow plate production technology that enables an accelerating fuel cell and electrolysis industry to scale up.Flow plate production is critically important for the growth of the hydrogen industry and at H2 MEET Cell Impact will share its experiences and knowledge from more than 50 flow plate projects involving a wide range of applications and materials. On September 14, at the

    There are no items matching the current filter
    There are no more items matching the current filter
    Back to top

    Subscribe

    Media